Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-101 dose-response in facial seborrheic keratosis
NCT02260180Phase 2Completed
- Sponsor
- Aclaris Therapeutics, Inc.
- Start
- Oct 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide gel in seborrheic keratosis (SK), sponsored by Aclaris Therapeutics, Inc.. Started Oct 2014; status: completed.
02
Drugs
hydrogen peroxide gel
03
Conditions
seborrheic keratosis (SK)
Beyond the preview
Go deeper on NCT02260180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260180.